SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 160,636.28 |
| Enterprise Value ($M) | 212,023.28 |
| Book Value ($M) | 7,527.00 |
| Book Value / Share | 14.00 |
| Price / Book | 21.34 |
| NCAV ($M) | -56,590.00 |
| NCAV / Share | -105.28 |
| Price / NCAV | -2.84 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.06 |
| Return on Assets (ROA) | 0.05 |
| Return on Equity (ROE) | 0.55 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.96 |
| Current Ratio | 1.32 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 26,766.00 |
| Assets | 90,883.00 |
| Liabilities | 83,356.00 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 9.16 | 2.02 | |
| 13G/A | State Street Corp | 5.52 | -0.73 | |
| 13G/A | BlackRock Inc. | 8.90 | -1.45 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 649,768 | 2,870,156 | 22.64 | |
| 1,076,748 | 5,765,490 | 18.68 | |
| 269,402 | 1,273,007 | 21.16 | |
| 273,966 | 1,203,890 | 22.76 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ALLO – Allogene Therapeutics, Inc. | ALNY – Alnylam Pharmaceuticals, Inc. |
| ALXO – ALX Oncology Holdings Inc. | AMLX – Amylyx Pharmaceuticals, Inc. |
| AMPH – Amphastar Pharmaceuticals, Inc. |